Last reviewed · How we verify
Colesevelam hydrochloride film-coated tablets — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Colesevelam hydrochloride film-coated tablets (Colesevelam hydrochloride film-coated tablets) — Genzyme, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Colesevelam hydrochloride film-coated tablets TARGET | Colesevelam hydrochloride film-coated tablets | Genzyme, a Sanofi Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Colesevelam hydrochloride film-coated tablets CI watch — RSS
- Colesevelam hydrochloride film-coated tablets CI watch — Atom
- Colesevelam hydrochloride film-coated tablets CI watch — JSON
- Colesevelam hydrochloride film-coated tablets alone — RSS
Cite this brief
Drug Landscape (2026). Colesevelam hydrochloride film-coated tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/colesevelam-hydrochloride-film-coated-tablets. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab